Clinical Trial Update: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

An NCI-sponsored Phase 1/2 trial of vincristine and temozolomide with PEN-866 in adolescents and young adults with relapsed or refractory solid tumors is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma
• Sarcoma

Drugs mentioned

• PEN-866
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma, Ewing, Rhabdomyosarcoma | Phase 1, Phase 2 | Status: SUSPENDED